1 result

    A study designed to establish the safety and effectiveness of the SAPIEN 3 Transcatheter Heart Valve (THV) in low-risk patients requiring aortic valve replacement who have severe, calcific, symptomatic aortic stenosis.

    Type: Device trial

    Principal Investigator: Sergio Waxman, MD

    Trial is open for enrollment

    For inquiries, call (973) 926-6938
    • Newark Beth Israel Medical Center